Terry Opgenorth, PhD

Terry Opgenorth, PhD







Terry joined CSU Ventures in 2007. Before that, he spent 20 years with Abbott Laboratories (now AbbVie) retiring as Vice President of Metabolic Disease, Antiviral and Target-Lead Discovery Research for its Global Pharmaceutical Division. He has also been President/CEO of Vidasym, and Co-Founder/CSO of VetDC. Terry serves as a Director on KromaTiD, VetDC, and UNeMed Boards. He previously served as Board Director for Colorado Institute for Drug, Device, and Diagnostic Development (CID4), Colorado Bioscience Association, and Keystone Symposia. Dr. Opgenorth holds a BA from Calvin College and MS and PhD degrees from University of Illinois Urbana-Champaign.